Comparison
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 vs 3m Syndrome 3 C3280146
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Fetoplacental Androgens Excess and 3M Syndrome 3 for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
A condition where the placenta and fetus together produce excess androgens, affecting an XX embryo's development. It is present at birth. Multidisciplinary care helps manage physical and hormonal aspects.
3m Syndrome 3 C3280146
A genetic condition causing intrauterine growth restriction and postnatal short stature with distinctive facial features. Treatment focuses on growth monitoring and supportive measures.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
Variable
3m Syndrome 3 C3280146
0-0
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
severe
3m Syndrome 3 C3280146
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
Chronic
3m Syndrome 3 C3280146
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
No
3m Syndrome 3 C3280146
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
reproductive
3m Syndrome 3 C3280146
musculoskeletal
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
endocrine
3m Syndrome 3 C3280146
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-fetoplacental-androgens-excess-C5679876 and 3m-syndrome-3-C3280146 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 | 3m Syndrome 3 C3280146 | Discriminating power |
|---|---|---|---|
| Genital development | XX embryo may show androgen-related atypical genital development at birth. | Genital atypicality is not a described core feature. | High |
| Growth pattern | Intrauterine growth restriction and short stature are not established core features. | Intrauterine growth restriction with postnatal short stature is characteristic. | High |
| Facial appearance | Distinctive facial features are not described in the source. | Distinctive facial features are part of the described phenotype. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 when
Atypical genital findings in an XX infant
The source centers on excess fetoplacental androgens affecting XX development.
High
Need for endocrine and reproductive assessment
Multidisciplinary hormonal and physical management is specifically described.
Moderate
No established growth-restriction phenotype
Absence of the 3M growth pattern makes that diagnosis less aligned.
Low
Choose 3m Syndrome 3 C3280146 when
Prenatal growth restriction and postnatal short stature
These are the principal described features of 3M syndrome 3.
High
Distinctive facial features with a suspected genetic condition
The source identifies a genetic growth disorder rather than an androgen-related DSD.
Moderate
Care focused on growth monitoring
Supportive growth surveillance is the stated management emphasis.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 | 3m Syndrome 3 C3280146 | Interpretation |
|---|---|---|---|
| Karyotype or sex-chromosome assessment | Source specifies an XX embryo; testing confirms chromosomal context. | No characteristic karyotype result is established here. | An XX result supports the stated DSD context but does not prove androgen excess. |
| Endocrine evaluation | Assessment may explore androgen-related findings; no cutoff is supplied. | No specific endocrine abnormality is established by the source. | Abnormal results require clinician interpretation and are not themselves a diagnosis. |
| Growth and genetic evaluation | Not the primary described evaluation. | Growth measurements and genetic assessment are relevant; exact criteria are not supplied. | A genetic result should be interpreted by a specialist before assigning the diagnosis. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
- Outcome
- A chronic congenital condition whose individual outcome is not established here.
- Factors
- Hormonal findings, anatomy, and access to multidisciplinary care may influence needs.
3m Syndrome 3 C3280146
- Outcome
- A chronic genetic condition with expected growth restriction and short stature.
- Factors
- Growth course and associated features influence supportive needs; exact outcomes are not supplied.
Time frame: From prenatal or birth presentation into long-term follow-up.
Accurate diagnosis, monitoring, and individualized supportive care are relevant; prognosis data are sparse.
Complications comparison
| Complication | Presentation |
|---|---|
| Hormonal or reproductive concerns | Physical and hormonal effects may require ongoing multidisciplinary care. Not described as a core complication. Specific complications and their frequency are not established. |
| Impaired linear growth | Not established from the supplied description. Postnatal short stature follows intrauterine growth restriction. Severity and adult height cannot be predicted from these data. |
| Psychosocial impact | Visible or sensitive developmental differences may affect support needs. Short stature and facial differences may affect support needs. Impact varies and should be assessed individually. |
Patient education highlights
- HighDifferent conditions
One primarily concerns XX sex development and androgen exposure; the other concerns genetic growth restriction and short stature.
- HighSpecialist interpretation
Test abnormalities, genetic findings, and physical features need clinician interpretation rather than self-diagnosis.
- MediumSupportive care
Care may include endocrine, reproductive, growth, genetic, and psychosocial support according to the confirmed condition.